Published December 19, 2022 | Version v1
Journal article Open

Antibody Characterization Report for Ubiquilin-2

  • 1. Montreal Neurological Institute
  • 2. Advanced BioImaging Facility (ABIF), McGill University

Description

Head-to-head comparison of available commercial antibodies against Ubiquilin-2 by immunoblot (Western blot), immunoprecipitation and immunofluorescence. The workflow and data collected in this study was used to create an article published on F1000, DOI: 10.12688/f1000research.131851.1.

The following study was funded in part by Genome Québec's Genomics Integration Program, awarded to the research laboratory of Peter S. McPherson. This work was supported by the ALS-Reproducible Antibody Platform (ALS-RAP). ALS-RAP was created as a public-private partnership by three leading ALS charities: the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.

Files

Ubiquilin-2_UBQLN2_YCharOS report_v2.pdf

Files (4.1 MB)

Name Size Download all
md5:4dd0696bff6640799a1267795d5b593d
4.1 MB Preview Download